Two-Pronged attack on liver cancer tested before surgery
NCT ID NCT06994299
Summary
This was a small, early study that planned to test a new combination treatment for liver cancer that could be removed with surgery. The goal was to see if giving a short course of targeted radiation along with two immunotherapy drugs before the operation was safe and showed signs of helping shrink the tumor. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New York-Presbyterian Weill Cornell Medical College
New York, New York, 11355, United States
Conditions
Explore the condition pages connected to this study.